Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
2.415
-0.005 (-0.21%)
Feb 27, 2026, 12:03 PM EST - Market open

Nautilus Biotechnology Analyst Ratings

Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$4.00
Upside
+65.63%

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Guggenheim
Guggenheim
Strong Buy
Maintains
$2.5$4
Strong BuyMaintains$2.5$4+65.63%Feb 27, 2026
Goldman Sachs
Goldman Sachs
Strong Sell
Downgrades
$2.25$1.75
Strong SellDowngrades$2.25$1.75-27.54%Dec 5, 2024
Guggenheim
Guggenheim
Strong Buy
Initiates
$6
Strong BuyInitiates$6+148.45%Jun 27, 2024
Jefferies
Jefferies
Hold
Initiates
$5$3
HoldInitiates$5$3+24.22%Jun 3, 2024
Morgan Stanley
Morgan Stanley
Hold
Reiterates
$6
HoldReiterates$6+148.45%Aug 3, 2023
Morgan Stanley
Morgan Stanley
Hold
Maintains
$8$6
HoldMaintains$8$6+148.45%Aug 3, 2022
Goldman Sachs
Goldman Sachs
Hold
Maintains
$4$2
HoldMaintains$4$2-17.18%Aug 3, 2022
Goldman Sachs
Goldman Sachs
Hold
Maintains
$5$4
HoldMaintains$5$4+65.63%Jul 14, 2022
Goldman Sachs
Goldman Sachs
Hold
Maintains
$9$5
HoldMaintains$9$5+107.04%Apr 13, 2022
Morgan Stanley
Morgan Stanley
Hold
Initiates
$8
HoldInitiates$8+231.26%Jan 6, 2022
Cowen & Co.
Cowen & Co.
Buy
Initiates
n/a
BuyInitiatesn/an/aNov 2, 2021
Goldman Sachs
Goldman Sachs
Hold
Initiates
$10
HoldInitiates$10+314.08%Aug 4, 2021
Jefferies
Jefferies
Strong Buy
Initiates
$13
Strong BuyInitiates$13+438.30%Jul 13, 2021